Actively Recruiting
Benefits of Individual Physical Activity Intervention on Health-related Quality of Life in Participants With Chronic Lymphocytic Leukemia
Led by Janssen Cilag S.A.S. · Updated on 2026-05-08
180
Participants Needed
1
Research Sites
178 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to assess the impact of an individual physical activity intervention (IPAI) on health-related quality of life (HRQoL) in participants with first line or relapsed chronic lymphocytic leukemia (CLL) initiating ibrutinib in a routine clinical practice setting. HRQoL will be measured using functional assessment of cancer therapy - general scale (FACT-G).
CONDITIONS
Official Title
Benefits of Individual Physical Activity Intervention on Health-related Quality of Life in Participants With Chronic Lymphocytic Leukemia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participants newly treated with ibrutinib for first line or relapsed chronic lymphocytic leukemia (treatment started within the last 8 days at most)
- Participants who agree to follow the individual physical activity intervention (IPAI)
- Participants who have or can use a compatible electronic device such as a smartphone, laptop, or tablet
- Participants with internet access at home and an email address
- Participants who agree to wear a connected watch 24 hours a day for the entire study duration
You will not qualify if you...
- Pregnant participants or those planning to become pregnant during the study
- Participants unable or deemed unsafe to practice physical activity
- Participants who received investigational drugs or invasive investigational medical devices within 90 days before joining the study
- Participants currently enrolled in another interventional study
- Participants likely to have difficulties using the digital tool independently
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Institut Universitaire du Cancer Toulouse Oncopole
Toulouse, France, 31059
Actively Recruiting
Research Team
S
Study Contact
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here